SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine
Department of Medicine

  Division of General Internal Medicine
[Return To Index page]
photo Walid F. Gellad, MD, MPH

Associate Professor of Medicine, School of Medicine

Associate Professor of Health Policy and Management,School of Public Health

Co-Director, Center for Pharmaceutical Policy and Prescribing

Follow on Twitter @walidgellad

Email: wfg3@pitt.edu

Phone: 412-360-2267
Contact
Office: Center for Health Equity Research and Promotion
University Drive (151C)
Pittsburgh, PA 15215
 
Phone: 412-360-2267
Fax:
E-mail: wfg3@pitt.edu
Education and Training
Education
BA, Music, Swarthmore College, 1997
MD, University of Maryland School of Medicine, 2002
MPH, Harvard School of Public Health, 2007
Training
Internal Medicine Residency, Brigham and Women's Hospital, 2005
General Medicine Fellowship, Brigham and Women's Hospital/Harvard Medical School, 2007
Chief Medical Resident, Brigham and Women's Hospital/Harvard Medical School, 2008
Research Interest
Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients. He was the recipient of a career development award from the Department of Veterans Affairs to study the quality and efficiency of prescribing in the VA and is currently funded by the VA, NIH, CDC, and the state of Pennsylvania on multiple studies of pharmaceutical policy and prescription use. His work spans clinical areas, from diabetes, to hepatitis c, to prescription drug and substance abuse. His policy area of expertise is prescription drug pricing and spending. He is a former member of the Food and Drug Administration (FDA) advisory committee on nonprescription drugs and currently an alternate member of the FDA Drug Safety Oversight Board.

Dr. Gellad is also a nationally recognized authority on improving the measurement of medication adherence. In 2015, he founded and chaired the first national conference focused on improving the science behind medication adherence measurement.

Dr. Gellad is board certified in internal medicine and completed a residency and chief residency in internal medicine at Brigham and Women's Hospital and Harvard Medical School. He sees primary care patients in the VA Pittsburgh Heathcare System and attends on the inpatient general medical service.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Gellad WF, Flynn K, Alexander GC. Evaluation of Flibanserin: Science and Advocacy at the FDA. JAMA. 2015.
Lo-Ciganic W, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF. Using Machine Learning to Examine Medication Adherence Thresholds and Risk of Hospitalization. Medical Care. 2015.
Anderson T, Dave S, Good CB, Gellad WF. Prevalence of Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors. JAMA. 2014; 311(13): 1353-5.
Gellad WF, Donohue JM, Zhao X, Mor MK, Thorpe CT, Smith J, Good CB, Fine MJ, Morden NE. Brand-Name Prescription Drug Use Among Veterans Affairs and Medicare Part D Patients with Diabetes: A National Cohort Comparison. Annals of Internal Medicine. 2013; 159(2).
Gellad WF, Donohue JM, Zhao X, Zhang Y, Banthin JS. The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It’s Still High For Many. Health Affairs. 2012; 31(2).
Donohue JM, Morden N, Gellad WF, Bynum J, Hanlon JT, Skinner J. Sources of Regional Variation in Medicare Part D Drug Spending. New England Journal of Medicine. 2012; 366(6).
Gellad WF, Grenard JL, Marcum ZA. A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity. American Journal of Geriatric Pharmacotherapy. 2011; 9 (1).
Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. RAND Technical Report. 2009; TR-765-MVC.
Gellad WF, Zhao X, Thorpe CT, Mor MK, Good CB, Fine MJ. Is Dual Use of Veterans Health Administration and Medicare Benefits Associated with Overuse of Test Strips in Veterans with Type II Diabetes?. JAMA Internal Medicine. 2015; 175(1): 26-34.
Sponsored Research/Activities
Title: Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose
Role: Principal Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: R01 DA044985
Start Year: 2017
End Year: 2020
Title: STORM Implementation Program Evaluation
Role: Principal Investigator
Funding Agency: HSR&D
Grant Number: SDR SDR 16-193
Start Year: 2016
End Year: 2016
Title: Safety of Opioid Use Among Veterans Receiving Care in Multiple Health Systems
Role: Principal Investigator
Funding Agency: VA HSR&D
Grant Number: I01 IIR 14-297
Start Year: 2015
End Year: 2018
Title: Early Impact of Health Reform
Role: Principal Investigator
Funding Agency: Express Scripts
Grant Number: XNV 72-200
Start Year: 2014
End Year: 2015
Title: The Economic and Clinical Impact of Hepatitis C Treatment on Pennsylvania
Role: Co-Principal Investigator
Funding Agency: Commonwealth of Pennsylvania
Grant Number: XNV 72-220
Start Year: 2014
End Year: 2015
Title: Dental Prescribing of Antibiotics and Opioids: High Use in the Absence of Evidence
Role: Co-Investigator
Funding Agency: University of Illinois
Grant Number: R01 HS025177
Start Year: 2017
End Year: 2021
Title: Dual Use of VA-Medicare Drug Benefits and Unsafe Prescribing in Dementia Patients
Role: Co-Investigator
Funding Agency: VA HSR&D
Grant Number: I01 IIR 12-379
Start Year: 2014
End Year: 2017
Title: The Influence of Formulary Management Strategies on Opioid Medication Use Amount - Patient and Prescribers
Role: Co-Investigator
Funding Agency: Center for Disease Control
Grant Number: U01 CE002496
Start Year: 2014
End Year: 2016
Title: The Influence of Formulary Management Strategies on Opioid Medication Use
Role: Co-Investigator
Funding Agency: Center for Disease Control
Grant Number: U01 CE002496
Start Year: 2014
End Year: 2016
Title: The Economic and Clinical Impact of Hepatitis C Treatment on Pennsylvania
Role: Co-Investigator
Funding Agency: Commonwealth of Pennsylvania
Start Year: 2014
End Year: 2015
Title: PA Medicaid Research and Data Analysis
Role: Co-Investigator
Grant Number: XVA 72-891
Start Year: 2014
End Year: 2014
Title: The Role of Physician Networks in the Adoption of New Prescription Drugs
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL119246
Start Year: 2013
End Year: 2017
Title: The Role of Physician Networks in the Adoption of New Prescription Drugs
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL119246
Start Year: 2013
End Year: 2017
Title: The Impact of Medicaid Reimbursement Policies on Pharmaceutical Spending
Role: Consultant
Funding Agency: Agency for Healthcare Research and Quality
Grant Number: R03 HS021567
Start Year: 2013
End Year: 2015
Notable Achievements
Summa cum laude, University of Maryland School of Medicine, 2002
Outstanding Reviewer, Annals of Internal Medicine, 2014
Noteworthy Article for 2014, Academy Health, 2014
Outstanding Reviewer, Annals of Internal Medicine, 2015
Member, HIT and Exchange Work Group for State Health Innovation Plan, Pennsylvania Department of Health, 2015
Member, FDA Advisory Committee on Nonprescription Drugs, 2009-2010, 2012-2013
Member, Editorial Board Journal of General Internal Medicine, 2016-
Excellence in Government Award, Federal Executive Board, 2016


Division of General Internal Medicine Academic Offices
UPMC Montefiore Hospital
Suite W933
Pittsburgh, PA 15213
Patient/clinical inquires: 412-692-4888
Administrative office: 412-692-4889
Pitt
Department of Medicine
School of Medicine

Copyright © 2016 Department of Medicine / University of Pittsburgh School of Medicine